<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05050578</url>
  </required_header>
  <id_info>
    <org_study_id>CLY935-C022</org_study_id>
    <nct_id>NCT05050578</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses</brief_title>
  <official_title>Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the clinical performance of LID018869 soft contact&#xD;
      compared to ACUVUE® OASYS with HYDRACLEAR® PLUS (AOHP) soft contact lenses over 30 days of&#xD;
      daily wear.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be expected to attend 6 visits. Subjects will be expected to wear their study&#xD;
      contact lenses every day at least 10 hours per day over a 30-day period per study lens type.&#xD;
      The total duration of a subject's participation in the study will be approximately 65 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance Visual Acuity (logMAR) with study lenses at Day 30</measure>
    <time_frame>Day 30, each wear period</time_frame>
    <description>Visual acuity (VA) will be collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA will be measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>LID018869, then AOHP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lehfilcon A contact lenses worn first, followed by senofilcon A contact lenses, as randomized. Each product will be worn in both eyes during waking hours only for at least 10 hours per day over a 30-day wear period per study lens type. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AOHP, then LID018869</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lehfilcon A contact lenses worn first, followed by senofilcon A contact lenses, as randomized. Each product will be worn in both eyes during waking hours only for at least 10 hours per day over a 30-day wear period per study lens type. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lehfilcon A contact lenses</intervention_name>
    <description>Commercially available, silicone hydrogel, spherical contact lenses used as indicated</description>
    <arm_group_label>AOHP, then LID018869</arm_group_label>
    <arm_group_label>LID018869, then AOHP</arm_group_label>
    <other_name>LID018869</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Senofilcon A contact lenses</intervention_name>
    <description>Commercially available, silicone hydrogel, spherical contact lenses used as indicated</description>
    <arm_group_label>AOHP, then LID018869</arm_group_label>
    <arm_group_label>LID018869, then AOHP</arm_group_label>
    <other_name>AOHP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CLEAR CARE</intervention_name>
    <description>Hydrogen peroxide-based contact lens cleaning and disinfecting solution</description>
    <arm_group_label>AOHP, then LID018869</arm_group_label>
    <arm_group_label>LID018869, then AOHP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Current wearer of a commercial spherical weekly/monthly soft contact lenses with at&#xD;
             least 3 months of wearing experience, with a minimum wearing time of 5 days per week&#xD;
             and 10 hours per day.&#xD;
&#xD;
          -  Manifest cylinder less than or equal to 0.75 diopter in each eye.&#xD;
&#xD;
          -  Best corrected distance visual acuity better than or equal to 20/25 Snellen in each&#xD;
             eye.&#xD;
&#xD;
          -  Other protocol-defined inclusion criteria may apply.&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Monovision or multifocal lens wearer.&#xD;
&#xD;
          -  Habitual senofilcon contact lens wearer (for example, Acuvue Oasys, Acuvue Vita) or&#xD;
             commercially available lehfilcon A contact lens wearer (TOTAL30).&#xD;
&#xD;
          -  Routinely sleeps in habitual contact lenses.&#xD;
&#xD;
          -  Other protocol-defined exclusion criteria may apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sr. Clinical Trial Lead, CDMA Vision Care</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research, LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alcon Call Center</last_name>
    <phone>1-888-451-3937</phone>
    <email>alcon.medinfo@alcon.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alcon Investigator 8062</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 8106</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94127</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 6356</name>
      <address>
        <city>Longwood</city>
        <state>Florida</state>
        <zip>32779</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 6355</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 6401</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02888</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 6353</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 1159</name>
      <address>
        <city>Smyrna</city>
        <state>Tennessee</state>
        <zip>37167</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 8114</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alcon Investigator 6594</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lenses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

